MB21D2
Nucleotidyltransferase MB21D2
Also known as: C3orf59, M21D2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IYB1
- Gene
- MB21D2
- Ensembl
- ENSG00000180611
- Chromosome
- 3
- Canonical length
- 491 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
Enables cadherin binding activity. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
491 residues, UniProt reviewed canonical sequence.
>Q8IYB1|MB21D2
1 MKMAAPTANK AASLGCNNKP AFPELDFRSG ARVEELNKLI QEFTKHDQRE YDDQRALEIH
61 TAKDFIFSML GMVQKLDQKL PVANEYLLLS GGVREGVVDL DLDELNVYAR GTDYDMDFTL
121 LVPALKLHDR NQPVTLDMRH SALCHSWLSL RLFDEGTISK WKDCCTIVDH INGATNYFFS
181 PTKVADWFYD SISIVLSEIQ KKPQRGMPKV EKVEKNGTII SIILGVGSSR MLYDIVPVVS
241 FKGWPAVAQS WLMENHFWDG KITEEEVISG FYLVPACSYK GKKDNEWRLS FARSEVQLKK
301 CISSSLMQAY QACKAIIIKL LSRPKAISPY HLRSMMLWAC DRLPANYLAQ EDYAAHFLLG
361 LIDDLQHCLV NKMCPNYFIP QCNMLEHLSE ETVMLHARKL SSVRSDPAEH LRTAIEHVKA
421 ANRLTLELQR RGSTTSIPSP QSDGGDPNQP DDRLAKKLQQ LVTENPGKSI SVFINPDDVT
481 RPHFRIDDKF FLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MB21D2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- placenta: 13 nTPM
- small intestine: 8.7 nTPM
- duodenum: 8.3 nTPM
- urinary bladder: 8.3 nTPM
- testis: 6.7 nTPM
- cerebellum: 5.4 nTPM
Single-cell type
- syncytiotrophoblasts: 424 nCPM
- endometrial luminal cells: 332 nCPM
- cytotrophoblasts: 319 nCPM
- urothelial cells: 235 nCPM
- thyrotrophs: 218 nCPM
- cdc: 212 nCPM
Immune cell
- memory CD4 T-cell: 4.2 nTPM
- T-reg: 3.9 nTPM
- naive CD4 T-cell: 2.6 nTPM
- MAIT T-cell: 1.9 nTPM
- memory CD8 T-cell: 1 nTPM
- total PBMC: 0.9 nTPM
Brain region
- cerebellum: 7.7 nTPM
- cerebral cortex: 6.7 nTPM
- basal ganglia: 6.6 nTPM
- hypothalamus: 5.7 nTPM
- white matter: 5.7 nTPM
- medulla oblongata: 5.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.69
- gnomAD pLI
- 0.04
- gnomAD missense Z
- 1.19
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MB21D2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MB21D2 as an antibody target. Whether an autoantibody or antibody against MB21D2 could matter depends on whether native MB21D2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MB21D2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MB21D2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...